简介：　　【摘要】 目的 探讨临床路径在猩红热患儿诊疗护理中的应用价值。方法 60例猩红热患儿， 随机分为对照组和临床路径组， 每组 30例。对照组患儿给予一般护理， 临床路径组患儿给予临床护理路径。比较两组患儿家属护理满意度 ;猩红热诊疗总时间、猩红热病情改善时间、治疗费用 ;护理前后生命质量指标以及心理健康指标 ;不良反应发生情况。结果 临床路径组患儿家属护理满意度为 100.00%（ 30/30）， 显著高于对照组的 70.00%（ 21/30）， 差异具有统计学意义（ P<0.05）。护理前， 两组患儿生理职能、社会功能、躯体功能、整体健康以及焦虑、抑郁评分比较， 差异均无统计学意义（ P>0.05）。护理后， 两组患儿的生理职能、社会功能、躯体功能及整体健康评分均明显高于护理前， 焦虑、抑郁评分均明显低于护理前， 且临床路径组患儿的生理职能、社会功能、躯体功能及整体健康评分均明显高于对照组， 焦虑、抑郁评分均明显低于对照组， 差异均具有统计学意义（ P<0.05）。临床路径组患儿猩红热诊疗总时间、猩红热病情改善时间分别为（ 8.41±3.12）、（ 3.41±1.34） d， 均明显短于对照组的（ 10.41±3.16）、（ 6.24±1.01） d， 治疗费用（ 5436.42±1343.22）元明显少于对照组的（ 7636.86±1367.22）元， 差异均具有统计学意义（ P<0.05）。临床路径组患儿不良反应发生率为 3.33%（ 1/30）， 明显低于对照组的 20.00%（ 6/30）， 差异具有统计学意义（ P<0.05）。结论  猩红热患儿实施临床护理路径可获得良好效果， 能够显著提高患儿的生命质量， 减轻焦虑、抑郁情绪， 缩短治疗时间， 减少治疗费用， 提高患儿家属护理满意度。  　　【关键词】 临床路径 ;猩红热 ;诊疗护理 ;应用价值  [Abstract] Objective To explore the application value of clinical pathway in the diagnosis, treatment and nursing of scarlet fever children. Methods 60 children with scarlet fever were randomly divided into control group and clinical pathway group, 30 cases in each group. The control group was given general nursing, the clinical pathway group was given clinical nursing pathway. The nursing satisfaction, the total time of diagnosis and treatment, the time of improvement of scarlet fever, the cost of treatment, the indicators of life quality and mental health before and after nursing, and the occurrence of adverse reactions were compared between the two groups. Results the nursing satisfaction of family members in clinical pathway group was 100.00% (30 / 30), significantly higher than that in control group (70.00% (21 / 30), the difference was statistically significant (P < 0.05). Before nursing, there was no significant difference in the scores of physiological function, social function, physical function, overall health, anxiety and depression between the two groups (P > 0.05). After nursing, the scores of physiological function, social function, physical function and overall health of children in the two groups were significantly higher than those before nursing, and the scores of anxiety and depression were significantly lower than those before nursing. The scores of physiological function, social function, physical function and overall health of children in the clinical pathway group were significantly higher than those in the control group, and the scores of anxiety and depression were significantly lower than those in the control group, The difference was statistically significant (P < 0.05). The total diagnosis and treatment time and the improvement time of scarlet fever in clinical pathway group were (8.41 ± 3.12), (3.41 ± 1.34) days, respectively, which were significantly shorter than those in control group (10.41 ± 3.16), (6.24 ± 1.01) days, and the treatment cost (5436.42 ± 1343.22) yuan was significantly lower than those in control group (7636.86 ± 1367.22), with statistical significance (P < 0.05). The incidence of adverse reactions in the clinical pathway group was 3.33% (1 / 30), which was significantly lower than that in the control group (20.00% (6 / 30). The difference was statistically significant (P < 0.05). Conclusion the implementation of clinical nursing pathway for children with scarlet fever can achieve good results, can significantly improve the quality of life of children, reduce anxiety and depression, shorten the treatment time, reduce the cost of treatment, and improve the nursing satisfaction of children's families.